ZheJiangTailin Bioengineering Co Ltd
SZSE:300813
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
ZheJiangTailin Bioengineering Co Ltd
SZSE:300813
|
CN |
|
E
|
Eurasia Groupe SA
XBER:JXE
|
FR |
|
Atlas Lithium Corp
NASDAQ:ATLX
|
US |
|
Corero Network Security PLC
LSE:CNS
|
UK |
|
AppBank Inc
TSE:6177
|
JP |
|
R
|
RLH Properties SAB de CV
BMV:RLHA
|
MX |
|
Argenica Therapeutics Ltd
ASX:AGN
|
AU |
|
Z
|
Zinzino AB
STO:ZZ B
|
SE |
|
Four Seasons Education (Cayman) Inc
NYSE:FEDU
|
CN |
|
Gbt Technologies Inc
OTC:GTCH
|
US |
|
Secure Energy Services Inc
TSX:SES
|
CA |
|
Great Eastern Holdings Ltd
SGX:G07
|
SG |
|
S
|
Shristi Infrastructure Development Corporation Ltd
BSE:511411
|
IN |
|
Godrej Industries Ltd
NSE:GODREJIND
|
IN |
|
L
|
LGMS Bhd
KLSE:LGMS
|
MY |
|
Chongqing Zaisheng Technology Co Ltd
SSE:603601
|
CN |
|
K
|
Kwangmu Co Ltd
KOSDAQ:029480
|
KR |
ZheJiangTailin Bioengineering Co Ltd
Zhejiang Tailin Bioengineering Co., Ltd. engages in the research, development, manufacturing, and sales of pharmaceutical equipment, including microbial detection and control technology system products, as well as organic substance analysis instruments. The company is headquartered in Hangzhou, Zhejiang and currently employs 869 full-time employees. The company went IPO on 2020-01-14. The firm's main business is the research, development, manufacturing and sales of microbial detection and control technology system products, organic substance analysis instruments and other pharmaceutical equipment. Specific products include various consumables, instruments and equipment, which can be used alone or in combination for the production and quality of sterile drugs. The application areas that can be expanded include medical and health, food safety, disease prevention and control, biosecurity, inspection and quarantine, biological engineering, laboratory animals, and environmental protection. The firm distributes its products within domestic market and to overseas markets.
Zhejiang Tailin Bioengineering Co., Ltd. engages in the research, development, manufacturing, and sales of pharmaceutical equipment, including microbial detection and control technology system products, as well as organic substance analysis instruments. The company is headquartered in Hangzhou, Zhejiang and currently employs 869 full-time employees. The company went IPO on 2020-01-14. The firm's main business is the research, development, manufacturing and sales of microbial detection and control technology system products, organic substance analysis instruments and other pharmaceutical equipment. Specific products include various consumables, instruments and equipment, which can be used alone or in combination for the production and quality of sterile drugs. The application areas that can be expanded include medical and health, food safety, disease prevention and control, biosecurity, inspection and quarantine, biological engineering, laboratory animals, and environmental protection. The firm distributes its products within domestic market and to overseas markets.
